GDF5 rs143383: Joint Health and Osteoarthritis Risk
The rs143383 variant is a common single-nucleotide polymorphism located in the regulatory promoter region of the GDF5 gene. It is widely investigated for its modest statistical association with cartilage maintenance, joint tissue dynamics, and risk of osteoarthritis, especially in weight-bearing joints like the knee. Carrying the T allele has been linked to slightly reduced expression of the anabolic growth factor GDF5 in joint tissues.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| CC | Carriers of two copies of the ancestral C allele exhibit typical GDF5 promoter activity in laboratory studies. This genotype is associated with baseline statistical risk for osteoarthritis and standard cartilage anabolic signaling in joint tissues. | Favorable |
| CT | Carriers of one C allele and one T allele possess intermediate GDF5 transcriptional activity. Research indicates an intermediate, modestly higher relative susceptibility to osteoarthritis compared to the CC genotype, though overall lifetime risk remains driven predominantly by lifestyle, biomechanics, and age. | Informational |
| TT | Carriers of two copies of the derived T allele have demonstrated reduced GDF5 messenger RNA expression in articular chondrocytes. This genotype is statistically associated with a modest increase in the relative odds of developing knee osteoarthritis compared to non-carriers. | Higher attention |
Genomic Location and Variant Biology
The single-nucleotide polymorphism rs143383 represents a cytosine-to-thymine (C/T) single-base transition located in the 5'-untranslated region (5'-UTR) and proximal promoter region of the Growth Differentiation Factor 5 (GDF5) gene on chromosome 20. Because it lies within a regulatory domain rather than an amino acid-coding sequence, rs143383 does not change the physical structure of the resulting protein. Instead, laboratory functional assays demonstrate that the variant alters local transcription factor binding and epigenetic regulation. Specifically, chromosomes carrying the derived T allele exhibit reduced promoter activity and produce significantly less messenger RNA transcript relative to those carrying the ancestral C allele. In synovial joint cells such as chondrocytes and synoviocytes, this lower transcriptional rate directly dampens the local production of GDF5.
The Biological Role of the GDF5 Gene
The GDF5 gene encodes Growth Differentiation Factor 5, also known as cartilage-derived morphogenetic protein 1 (CDMP-1), a specialized signaling molecule belonging to the transforming growth factor-beta (TGF-beta) superfamily. GDF5 is essential for skeletogenesis, synovial joint cavitation, and lifelong joint homeostasis. In healthy adult joints, GDF5 provides critical anabolic signaling that stimulates chondrocytes to synthesize key extracellular matrix components, including type II collagen (encoded by COL2A1) and aggrecan (encoded by ACAN). Furthermore, GDF5 assists in tissue repair following mechanical stress or minor micro-trauma. When GDF5 availability is suppressed, the delicate balance between cartilage breakdown and cellular regeneration tilts toward degradation, leaving articular surfaces more susceptible to wear.
Research Findings and Evidence Strength
Genome-wide association studies (GWAS) and extensive meta-analyses have consistently identified the T allele of rs143383 as a modest genetic risk factor for osteoarthritis. The statistical association is most robust and reproducible for primary knee osteoarthritis across multiple ancestral cohorts, whereas associations with hip, spine, or hand osteoarthritis have shown greater variability across published studies. Because osteoarthritis is a complex polygenic disorder influenced by dozens of loci along with age, body mass index, joint injury history, and physical biomechanics, the individual effect size of rs143383 is small (odds ratios typically range from 1.15 to 1.30 per risk allele). Evidence linking rs143383 directly to acute athletic injury or exercise-induced wear remains limited, meaning the variant acts as a minor statistical modifier rather than a direct causative factor.
Population Distribution and Evolutionary Context
The rs143383 variant exhibits striking divergence in allele frequencies across world populations. The ancestral C allele is more prevalent among individuals of African ancestry, whereas the derived T allele has reached substantial frequencies outside of Africa. In European populations, the minor allele frequency of the T allele is roughly 38% to 45%. In East Asian populations, the derived T allele is the major allele, with frequencies frequently reaching 65% or higher. Evolutionary biologists have suggested that positive natural selection shaped the distribution of the rs143383 T allele in non-African groups, potentially in connection with selective pressures favoring compact skeletal morphology or reduced limb growth during human migrations through colder climates.
Interpreting Your Genetic Results
Discovering your rs143383 genotype provides general educational context regarding your genetic background, but it cannot diagnose osteoarthritis or predict joint failure. Possessing one or two copies of the T allele does not mean an individual is destined to develop cartilage problems or knee discomfort, just as carrying the CC genotype does not provide immunity from joint damage. Modifiable environmental variables—including maintaining a healthy body weight, engaging in low-impact resistance training to support surrounding musculature, and practicing safe exercise mechanics—play far greater roles in lifelong joint health than any single genetic variant. Individuals with chronic joint pain or mobility concerns should seek personalized guidance from a qualified physician or physical therapist.
How common is this variant?
The derived T allele occurs at an estimated frequency of 38% to 45% in European populations and reaches approximately 65% to 75% in East Asian cohorts, while remaining least frequent in populations of recent African ancestry.
Frequently asked questions
Does having the rs143383 T allele mean I will get osteoarthritis?
No. The rs143383 T allele confers only a small, incremental increase in relative risk rather than a definitive outcome. Osteoarthritis is a complex condition driven predominantly by aging, mechanical wear, prior physical trauma, and overall body composition.
Can I prevent joint issues if I carry the higher-risk genotype?
Yes, focusing on established joint-protective habits provides significant benefits regardless of genetics. Maintaining a healthy weight, strengthening the quadriceps and hamstring muscles, and avoiding high-impact joint overload are proven strategies for joint preservation.
Why is the GDF5 gene important for cartilage?
GDF5 produces a signaling protein that stimulates chondrocytes to make essential building blocks like type II collagen and aggrecan. These proteins form the cushioned matrix that allows joints to absorb shock and glide smoothly.
Is rs143383 linked to any other musculoskeletal conditions?
Beyond osteoarthritis, researchers have evaluated rs143383 in studies examining variation in adult height, hip dysplasia, and susceptibility to chronic joint discomfort. However, the evidence for these additional traits varies significantly across different study populations.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs143383?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29